Navigation Links
India to Set Up Nicotine-Mapping Laboratory

India will soon set up a laboratory of international standards to test the percentage of nicotine in tobacco products made in the country //or coming from outside to help in the fight against tobacco-related diseases, Health Minister Anbumani Ramadoss said Tuesday.

The tobacco-testing laboratory is to come up in Ahmedabad, Gujarat, in collaboration with the Atlanta-based Center for Disease Control and Prevention (CDC).

Ramadoss said the government would make it mandatory for all tobacco manufacturers to mention the percent of nicotine in their products, as per a 2003 decision.

"Currently we don't have the facility to test it and the new lab will enable us in our endeavour," he told reporters here.

The minister said the laboratory would be the first of its kind in South and Southeast Asia but did not give a time frame within which it would be built.

"A lab is there in Brazil, which works in a similar fashion and earns money. The income generated through such activities can be used to promote the anti-tobacco drive in the country," the minister said after a meeting with visiting dignitaries from CDC.

CDC director Julie L. Gerberding, who is on a three-day visit to India, said tobacco was one of the key factors responsible for many diseases.

"The new initiative will help India and the global community in their fight against the health menace," she said, adding that her organisation would aid in providing technical know-how and human expertise for the laboratory.

Talking about the decision to make pictorial warnings mandatory on bidi packets, Ramadoss said his government was for a tobacco free environment and would continue to push for it.

"Thousands of people die every year due to tobacco-related disease and there are over three million people who are currently taking tobacco in India. My effort is to safeguard their health through available ways.

"Th
'"/>




Page: 1 2

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: India Set Nicotine Mapping Laboratory

(Date:5/16/2008)...delines quickly disseminated to community physicia...thDay News) -- Partnerships between major academic...k and effective way to spread cancer treatment adv...in Philadelphia. , Most new cancer treatments a...er care is provided at community hospitals, noted ...
(Date:5/16/2008)...in some early stage cases makes therapy of little ...ay 16 (HealthDay News) -- Colon cancer patients wi...receive chemotherapy. In fact, not only does chemo... actually harm them, a new study found. , "If yo...hen you should not be treated with chemotherapy. S...
(Date:5/16/2008)...a., May 16 /PRNewswire-USNewswire/ -- The Centers ...gency for Toxic Substances and,Disease Registry (A...,Health Improvement Award for 2008. Since its 1999... Stockpile (DSNS) in the CDC Coordinating Office,f...with LMI,s Health,Systems Management group, supple...
(Date:5/16/2008)... scheduled for Pittsburgh Zoo & PPG Aquarium for M...r Life, the Medicare product,of UPMC Health Plan, ...ual,National Senior Health & Fitness Day, which ha....", National Senior Health & Fitness Day is sched...will serve as host for three events in,Pennsylvani...
Breaking Medicine News(10 mins):Health News:Partnerships Effective Communicators of Cancer Advances 2Health News:Not All Colon Cancer Patients Need Chemotherapy: Study 2Health News:UPMC for Life is Pennsylvania Sponsor for National Senior Health & Fitness Day 2
...lth Service reform said that local hospitals shoul...ble.// Andrew Foster, the outgoing workforce direc...s ingrained practices have to undergo a change. Th...atients greater choice and allowing more hospitals...
...thwestern state of Sokoto has killed at least five...igeria.// The cases of Cerebra Spinal Meningitis ...t area. Initial figures reveal that at least 14 pe...break of measles has also been reported in the are...
...ing to India and desperate to do so. It is not to ...hes// of Goa but to rid themselves of the extra fl...Amir a Bangladesh-born American and Hardeep a Sikh...e to get in shape. The hub of laparoscopic surgeri...
...ope Benedict XVI’s intention of soliciting a repor... benefits of condom use //in exceptional cases, su...ed with H.I.V, with a view to protect life within ...ve commended the efforts of the church to have add...
Other Medicine News:Health News:India is the "IT" destination for obesity cure: med tourism 2
(Date:5/16/2008)...l Mechanism May Offer Novel Approach to Blood ...EANS, May 16 /- Pharmacopei...d development of novel small,molecule therapeutics...s,Dual Acting Receptor Antagonist (DARA), showed s... in a Phase 2a study in patients with mild to,mode...
(Date:5/15/2008)... 15 /- Patients with breast or,colore...s, can expect,further treatment advances with Avas...) following new data that is being presented at th...) annual meeting in Chicago at,the end of May. Aro... which,is the premier event for cancer therapy wor...
(Date:5/15/2008)...t ASCO Showed Acceptable Tolerability Profile, ...pathy, WOODCLIFF LAKE, N.J., May 15 /PRNewswire/ ...ulin mesylate (E7389) demonstrated activity in a,h... advanced or metastatic,breast cancer, according t...l. The study also suggests that eribulin mesylate ...
(Date:5/15/2008)...emonstrated in Blacks, Hispanics/Latinos, People ...s, PARSIPPANY, N.J., May 15 /- Daiic...ed at the American Society of,Hypertension,s Twent...ew,Orleans demonstrated that the powerful combinat...omil) safely and effectively helped,patients acros...
Breaking Medicine Technology:Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Media Invitation Annual General and Special Meeting of Shareholders of Haemacure 16206 1Media Invitation Annual General and Special Meeting of Shareholders of Haemacure 16206 2Navigenics 28TM 29 Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments 1702 1Navigenics 28TM 29 Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments 1702 2Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision 4447 1Study Shows the Personal Touch Is Key to Maintaining Weight Loss 16201 1Study Shows the Personal Touch Is Key to Maintaining Weight Loss 16201 2
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications.
The Guidant Flextend lead is a steroid-eluting, transvenous pace/sense lead with an extendable/retractable active-fixation helix. The extendable/retractable helix design offers various lead placement
The Vitatron Impulse II lead series are silicon rubber endocardial leads specifically designed to extend the longevity of the pacemaker system by providing energy efficient pacing. The high impedance
The RZ is a small lead body profile implantable unipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model).
Medicine Products: